Medical Doctor Program year 2023 Reported 2020–2023 Source: CMS Open Payments, 2026 publication

Ajit Alexander

Critical Care Medicine Shreveport, LA Medical Doctor

NPI 1861888760 CMS profile 8790149

Po Box 19284, Shreveport, LA 71149

Open in the dashboard

General payments

$1,552

66 records reported · program years 2020–2023

Research payments

$0

Paid to them · None reported · program years 2020–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Ajit Alexander of Shreveport, LA is reported in the CMS Open Payments database as having received $1,552 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $167 7
2022 General $560 19
2021 General $583 31
2020 General $242 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ajit Alexander
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to Ajit Alexander were reported at $0. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.

Show as a table
Year Ajit Alexander Critical Care Medicine median Middle half National median
2019 $0 $149 $51–$535 $163
2020 $242 $110 $30–$325 $114
2021 $583 $125 $34–$403 $132
2022 $560 $157 $49–$582 $149
2023 $167 $162 $56–$621 $160
2024 $0 $168 $53–$634 $164
2025 $0 $189 $59–$844 $169

Breakdown

Who paid General payments · program years 2020–2023
  1. Insmed, Inc. $263 7 payments
  2. AstraZeneca Pharmaceuticals LP $243 8 payments
  3. Actelion Pharmaceuticals US, Inc. $208 15 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $191 10 payments
  5. Abiomed $128 1 payment
  6. Baxter Healthcare $98 1 payment
  7. Janssen Pharmaceuticals, Inc $63 4 payments
  8. Edwards Lifesciences Corporation $62 2 payments
  9. Merck Sharp & Dohme Corporation $57 4 payments
  10. Inari Medical, Inc. $55 2 payments
  11. Other $182 12 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2023
  1. Food and Beverage $1,467 65 payments
  2. Education $85 1 payment
Products named General payments · program years 2020–2023
  1. Arikayce $263 7 payments
  2. LOKELMA $243 8 payments
  3. OPSUMIT $208 15 payments
  4. Impella $128 1 payment
  5. OFEV $127 5 payments
  6. Gambro - Accute $98 1 payment
  7. SPIRIVA RESPIMAT $64 5 payments
  8. XARELTO $63 4 payments
  9. RECARBRIO $57 4 payments
  10. FLOWTRIEVER CATHETER, S $55 2 payments
  11. Other $419 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$48,523

Medicare's payments for the services billed

Medicare patients

187

Average age 75

Services billed

461

90 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 68%
Heart failure 65%
Diabetes 60%
Chronic kidney disease 58%
Atrial fibrillation 57%
Arthritis 57%
COPD 47%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record